ROS signalling in the biology of cancer

Area of Science:

• Oncology
• Biochemistry
• Cell Biology

Background:

• Increased reactive oxygen species (ROS) production is a hallmark of cancer, influencing tumor progression and survival.
• Tumor cells maintain altered redox balance by upregulating antioxidant systems to support pro-tumourigenic signaling and evade apoptosis.

Purpose of the Study:

• To review the generation, sources, and regulation of ROS in cancer cells.
• To explore the dual pro- and anti-tumourigenic roles of ROS signaling.
• To provide insights into manipulating ROS pathways for cancer therapy.

Main Methods:

• Literature review of ROS generation, antioxidant systems, and signaling pathways in cancer.
• Analysis of the dual role of ROS in promoting tumor growth and inducing cell death.
• Discussion of therapeutic strategies targeting ROS in cancer treatment.

Main Results:

• ROS can activate pro-tumourigenic signaling, enhance cell survival, and drive DNA damage.
• ROS also initiate anti-tumourigenic signaling, leading to oxidative stress-induced tumor cell death.
• Tumor cells' altered redox balance presents a therapeutic vulnerability.

Conclusions:

• ROS are critical mediators in cancer, with both tumor-promoting and tumor-suppressing effects.
• Targeting the redox balance in cancer cells by manipulating ROS is a viable therapeutic approach.
• Further research into ROS signaling pathways can lead to novel cancer treatment strategies.